38.6
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogen…
Metastasis is a multi-step process, where the tumor cells overcome several challenges to spread from the primary site to form secondary tumors in the body. As few as one in a million cells manage to achieve metastasis.
Normal cells are confined to their tissue of origin by cell-cell adhesion and the basement membrane, which is a physical barrier present between tissues. Cancer cells overcome the tissue constraints by a process called epithelial to mesenchymal transition or EMT.
This transition activates two transcription factors, Snail and Twist, which promote the expression of genes involved in cell migration and down-regulate the cell-adhesion factors such as E-cadherin.
Transformed cells then penetrate the basement membrane by extending invadopodia, the actin-rich protrusions. Invadopodia secrete proteases, which degrade the basement membrane.
Once they are freed from the tissue constraints, the transformed cells reach the blood vessel by modifying the extracellular matrix.
Tumor cells then breakdown the basement membrane of the vessel and squeeze through the epithelial cells’ tight junctions to enter the blood circulation by a process called intravasation.
The majority of the circulating tumor cells or CTCs die during circulation due to lack of cell-cell adhesion and also by immune surveillance. Some CTCs secrete substances like thrombin, and cancer procoagulant, to stimulate platelet coating around them. This helps CTCs escape the shear stress during circulation and also to escape immune surveillance.
In addition, certain CTCs express survivin proteins that suppress the action of cytotoxic natural killer cells.
Initially, the CTCs adhere weakly to the endothelial cells via adhesion molecules and roll along the vessel lining until they form a firm attachment to the vessel. Then they squeeze through the vessel’s endothelial lining, digest the basement membrane and enter a new, distant tissue by a process called extravasation.
Once in the new site, the tumor cells adapt to the foreign tissue environment to form microcolonies and eventually proliferate to form macroscopic secondary tumors.
View the full transcript and gain access to JoVE Core videos
Q1: What is metastasis in cancer?
Metastasis is the process by which cancer cells spread from a primary tumor to distant sites in the body, forming secondary tumors. This occurs when malignant cells break away from the original tumor, enter the bloodstream or lymphatic system, and establish new colonies in other organs or tissues. Metastasis represents an advanced stage of cancer and is a major factor in cancer mortality and treatment complexity.
Q2: How do cancer cells travel through the body during metastasis?
Cancer cells disseminate through two primary routes: the bloodstream and the lymphatic system. Cells invade blood vessels or lymph vessels, survive circulation, and lodge in distant tissues where they establish new tumors. This process requires cancer cells to evade immune detection, resist mechanical stress, and adapt to new tissue environments, making metastasis a complex and selective biological process.
Q3: What are the key differences between primary and secondary tumors?
A primary tumor originates at the initial cancer site, while secondary tumors form when metastatic cancer cells establish growth in distant locations. Secondary tumors are genetically derived from the primary tumor but may acquire additional mutations during spread. Both require similar treatment approaches, though secondary tumors often indicate more advanced disease and present greater therapeutic challenges.
Q4: Why is metastasis considered the most dangerous stage of cancer?
Metastasis is dangerous because it indicates cancer has spread beyond the primary site, making surgical removal and localized treatment less effective. Multiple secondary tumors throughout the body require systemic therapy and complicate prognosis. Metastatic cancer is significantly harder to treat and has lower survival rates than localized disease, making early detection and prevention of spread critical.
Q5: Which organs are most commonly affected by metastatic cancer?
Common sites for metastatic spread include the lungs, liver, bones, and brain. These organs receive high blood flow and provide favorable microenvironments for cancer cell survival and growth. The specific organs affected depend on the cancer type and the biological properties of the primary tumor cells, which determine their tropism for particular tissues.
Q6: How does metastasis affect cancer diagnosis and treatment planning?
Detection of metastasis changes cancer staging from localized to advanced, fundamentally altering treatment strategy. Diagnosis typically involves imaging studies and biopsies to identify secondary tumors. Treatment shifts from surgery alone to multimodal approaches including chemotherapy, radiation, and targeted therapies designed to address systemic disease rather than isolated tumors.